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Abstract Binding of PDC-109, the major protein of the bovine
seminal plasma, to sperm plasma membrane results in an e¥ux
of cholesterol and choline phospholipids, a necessary event be-
fore capacitation can occur. The selectivity of PDC-109 for
di¡erent spin-labelled phospholipids and sterol probes in dimy-
ristoylphosphatidylcholine (DMPC) host matrix has been char-
acterized earlier by EPR spectroscopy [Ramakrishnan, M., An-
bazhagan, V., Pratap, T.V., Marsh, D. and Swamy, M.J.
(2001) Biophys. J. 81, 2215^2225]. In this report the e¡ect of
cholesterol on the interaction of PDC-109 with DMPC mem-
branes has been investigated by spin-label EPR spectroscopy.
The results indicate that the presence of cholesterol leads to an
increased association of di¡erent phospholipid as well as sterol
probes, thus modulating the interaction of PDC-109 with phos-
pholipid membranes. 7 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
In mammals, the seminal plasma carries the ejaculated sper-
matozoa through the female genital tract to their ¢nal desti-
nation, the uterus. It is a highly complex £uid containing a
variety of small molecules, but interestingly contains only
proteins as the high molecular weight constituents, whereas
other biopolymers such as polysaccharides and nucleic acids
are not present [2]. Among the di¡erent mammalian species,
considerable attention has been focused on the proteins from
bovine seminal plasma. There are four closely related proteins
in the bovine seminal plasma, namely BSP-A1, BSP-A2, BSP-
A3 and BSP-30kDa protein, which bind to sperm plasma
membrane [3^5]. Collectively these proteins are referred to
as bovine seminal plasma proteins, or in short, as BSP proteins.
BSP-A1 and BSP-A2 are identical in their primary structure
of 109 amino acid residues and di¡er only in glycosylation. A
mixture of the glycosylated and unglycosylated forms of this
protein is referred to as PDC-109. The 109 amino acid resi-
dues of this protein are arranged in three parts; a 23-residue
amino terminal peptide followed by two tandemly repeating
¢bronectin type-II (Fn-II)1 domains [6^8]. PDC-109 is the
major protein of the bovine seminal plasma and is present
at V15^25 mg/ml concentration [9]. The three-dimensional
structure of the PDC-109/phosphorylcholine complex indi-
cates that the two binding sites for the ligand are on the
same face of the protein molecule [10].
BSP proteins bind to sperm cell membranes by their speci¢c
interaction with the choline containing phospholipids, namely
phosphatidylcholine (PC) and sphingomyelin (SM) [5]. This
binding results in an e¥ux of choline phospholipids and cho-
lesterol, referred to collectively as cholesterol e¥ux. Cholester-
ol e¥ux results in a decrease of the cholesterol/phospholipid
ratio and promotes capacitation, which is a necessary event
before the sperm can undergo acrosome reaction and ¢nally
fertilize the egg [11,12].
Each Fn-II domain of PDC-109 binds to one choline phos-
pholipid molecule and both binding sites are necessary for
inducing cholesterol e¥ux [13]. In order to understand at
the molecular level how cholesterol e¥ux is induced by this
protein, it is important to investigate its interaction with phos-
pholipid membranes with and without cholesterol. Such stud-
ies are expected not only to shed light on the molecular events
involved in the capacitation process but can potentially lead
to the development of novel anti-fertility drugs. In an earlier
study we investigated the interaction of PDC-109 with PC
membranes bearing probe amounts of di¡erent spin-labelled
phospholipids and sterols by electron paramagnetic resonance
(EPR) spectroscopy. These studies showed that, in addition to
spin-labelled PC and SM, PDC-109 also recognizes phospha-
tidylserine and phosphatidylglycerol spin labels as well as a
cholesterol analogue, androstanol spin label with considerable
a⁄nity, whereas very weak interaction was observed with
spin-labelled phosphatidylethanolamine [1]. In the present
study, the interaction of PDC-109 with model membranes
made up of dimyristoylphosphatidylcholine (DMPC) and cho-
lesterol are investigated by spin-label EPR spectroscopy. The
results obtained indicate that the interaction of PDC-109 with
di¡erent phospholipids is increased considerably by the pres-
ence of cholesterol.
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2. Materials and methods
2.1. Materials
Phosphorylcholine chloride (Ca2þ salt), choline chloride and Tris
base were from Sigma (St. Louis, MO, USA). Sephadex G-50 (super-
¢ne), DEAE Sephadex A-25 and DEAE Sephadex A-50 were ob-
tained from Pharmacia Biotech (Uppsala, Sweden). DMPC and cho-
lesterol were obtained from Avanti Polar Lipids (Alabaster, AL,
USA). Stearic acid spin labelled on the 14th C-atom and PC, spin
labelled on the 14th C-atom of the sn-2 acyl chain (14-PCSL; 1-acyl-
2-[n-(4,4-dimethyloxazolidine-N-oxyl)]stearoyl-sn-glycero-3-phospho-
choline) were synthesized according to procedures outlined in [14].
Spin-labelled phospholipids with di¡erent polar headgroups (14-
PESL, phosphatidylethanolamine and 14-PSSL, phosphatidylserine)
were prepared from 14-PCSL by phospholipase D-catalyzed head-
group exchange, as described in [14]. Spin-labelled SM (14-SMSL)
was prepared as described in [15]. Cholestan spin label (4P,4P-dime-
thylspiro[5K-cholestane-3,2P-oxazolidin]-3P-yloxyl) and androstanol
spin label (17L-hydroxy-4P,4P-dimethylspiro[5K-androstan-3,2P-oxazo-
lidin]-3P-yloxyl) were obtained from Syva (Palo Alto, CA, USA).
PDC-109 was puri¢ed and characterized as described previously [1].
The concentration of puri¢ed PDC-109 was estimated from its extinc-
tion coe⁄cient at 280 nm of 2.5 for a 1 mg/ml sample concentration
[16].
2.2. Electron paramagnetic resonance spectroscopy
EPR spectra were recorded on a Varian E-12 Century Line 9 GHz
ESR spectrometer. Details of sample preparation and instrumental
settings for ESR spectroscopy have been described earlier [1]. Spectral
subtractions were performed essentially as described in [17], using a
program written by Dr. Jo«rg H. Kleinschmidt. Details of measuring
the values of the outer hyper¢ne splitting, 2Amax, and spectral sub-
tractions are given in [1]. Reference spectra for the motionally re-
stricted components were selected from a library of spectra of 14-
PCSL bound to the proteolipid protein from bovine myelin, recorded
at di¡erent temperatures. Reference spectra for the £uid components
were taken either from spectra of the same spin-labelled lipid in the
lipid mixture alone recorded at a slightly lower (by ca. 2^4 degrees)
temperature or from a library of spectra of 14-PCSL in lipid extracts
from the (Naþ,Kþ)-ATPase membranes of Squalus acanthias [18].
Reference spectra for the £uid components obtained from DMPC
membranes in the presence of PDC-109 were taken from a library
of spectra of 14-PCSL in egg yolk PC, recorded at di¡erent temper-
atures [1].
3. Results and discussion
The e¡ect of cholesterol on the stoichiometry of PC asso-
ciation with PDC-109 was studied using a PC probe spin
labelled on the 14th C-atom of the sn-2 chain. Lipids interact-
ing directly with the protein appear as a second, motionally
restricted component in the spin-label EPR spectrum. The
e¡ect of cholesterol on the selectivity of lipid association
with PDC-109 was studied similarly by using di¡erent spin-
labelled phospholipid and sterol species.
3.1. Binding of PDC-109 to DMPC/cholesterol membranes
In order to investigate the e¡ect of cholesterol on the bind-
ing of PDC-109 to PC membranes, the initial experiments
were carried out with £uid DMPC membranes containing
di¡erent amounts of cholesterol (0^20 wt%) and 1 mol% of
spin-labelled PC, 14-PCSL. EPR spectra were obtained in the
presence as well as in the absence of PDC-109 at a protein/
lipid ratio of 2.5 (w/w). In each case the spectrum obtained in
the presence of protein is made up of two components. These
two components have been resolved by spectral subtraction.
Spectra obtained in the presence of PDC-109 and the subtrac-
tion results are shown in Fig. 1. In each set of four spectra the
top pair correspond to the composite spectrum obtained in
the presence of PDC-109 at 30‡C (solid line) and a matching
spectrum for the motionally restricted component alone (dot-
ted line). The lower pair of spectra correspond to the £uid
component obtained by subtracting the rigid component spec-
trum from the composite spectrum (solid line) and a matching
£uid reference spectrum (dotted line). The fraction, f, of im-
mobilized component obtained from spectral subtraction is
also shown in the ¢gure. The results indicate that presence
of cholesterol has a signi¢cant e¡ect on the size of the mo-
tionally restricted lipid component, the motionally restricted
population being higher in the presence of cholesterol. This
suggests that cholesterol potentiates the binding of PDC-109
to PC membranes. However, over the range of 5^20 wt%
cholesterol, the motionally restricted fraction remains con-
stant, or increases only slightly, within the range of error
expected in the subtractions. Evidently, only relatively low
concentrations of cholesterol are necessary to potentiate the
PDC-109 binding.
3.2. Lipid selectivity of PDC-109 in DMPC/cholesterol
membranes
In further experiments, aimed at investigating the e¡ect of
cholesterol on the lipid selectivity, we have used £uid DMPC
Fig. 1. E¡ect of cholesterol on the motionally restricted component
of EPR spectra of 14-PCSL in membranes of DMPC and DMPC/
cholesterol mixtures. In each set of four spectra, the upper pair cor-
responds to the spectrum obtained in the presence of PDC-109 at
30‡C (solid line) and a matching spectrum for the motionally re-
stricted component alone (dotted line). The lower pair corresponds
to the £uid component obtained from spectral subtraction (solid
line) and a matching £uid reference spectrum (dotted line). The
fraction of cholesterol in the host membrane and the fraction of
motionally restricted lipid component, f, obtained from spectral sub-
traction are indicated.
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membranes containing 20% (wt/wt) cholesterol as the host
matrix, and 1 mol% of the desired spin-labelled lipid probe
was incorporated into the lipid membranes. EPR spectra were
recorded for the lipid samples alone and after addition of
PDC-109 at a lipid/protein ratio of 1:2.5 (w/w). Representa-
tive spectra of di¡erent spin-labelled lipids in the absence and
in the presence of PDC-109, recorded at 30‡C, are given in
Fig. 2. For all the spin labels investigated, the EPR spectra
obtained in the presence of PDC-109 are composed of two
components, as was the case with di¡erent spin-labelled lipids
in DMPC membranes without cholesterol in the presence of
PDC-109 [1]. The relative amounts of the two components in
each spectrum are di¡erent, indicating the selectivity of the
PDC-109 protein for di¡erent lipid species.
The two components in the EPR spectra of di¡erent spin-
labelled lipid probes obtained in the presence of PDC-109
have been resolved by spectral subtractions and the relative
contributions of each component to the overall spectrum have
been quanti¢ed. The results obtained are shown in Fig. 3 for
several of the spin labels. In each set of four spectra the top
pair corresponds to the composite spectrum obtained in the
presence of PDC-109 at 30‡C (solid line) and a matching
spectrum for the motionally restricted component alone (dot-
ted line). The lower pair of spectra corresponds to the £uid
component obtained by subtracting the motionally restricted
component spectrum from the composite spectrum (solid
line), and the spectrum of the same spin label, recorded in
DMPC:cholesterol (80:20, w/w) at 30‡C (dotted line). The
relative amounts of the motionally restricted components
(fraction, f) for the di¡erent spin-labelled lipids in the pres-
ence of PDC-109, obtained from the spectral subtractions, are
given in Table 1. The e¡ect of cholesterol on the speci¢city of
PDC-109 for di¡erent lipid species and the corresponding
lipid^protein stoichiometry is discussed below.
3.3. E¡ect of cholesterol on lipid stoichiometry and speci¢city
The equilibrium spin-label lipid^protein association can be
described by (e.g. [19]) :
1
f
31 ¼ 1
Kr
nt
Nb
31
 
ð1Þ
where f is the fraction of motionally restricted spin-labelled
lipid, nt is the ratio of lipid to bound protein, Nb is the num-
ber of lipid association sites on the protein and Kr is the
association constant of the spin-labelled lipid relative to the
host lipid. The association constant of a given spin-labelled
lipid, relative to spin-labelled PC, is given by:
K r
KPCr
¼ 1=f
PC31
1=f31
ð2Þ
Fig. 2. EPR spectra of di¡erent phospholipid spin labels, 14-XXSL,
bearing the spin label on the 14th C-atom of the sn-2 chain, as well
as the cholestane spin label (CSL) and androstanol spin label
(ASL), in DMPC membranes containing 20 wt% cholesterol. Spec-
tra are shown for lipid mixture alone (dotted line) and in the pres-
ence of PDC-109 (lipid:protein, 1:2.5 w/w) (solid line). Phospholipid
spin labels are: 14-PCSL, 14-SMSL, 14-PSSL and 14-PESL. Spectra
were recorded at 30‡C. The spectral width is 100 G.
Fig. 3. Representative spectral subtractions for 14-position spin la-
bels. Spectra of 14-PCSL, 14-SMSL, 14-PSSL and 14-PESL in
DMPC/cholesterol (80:20, w/w) host matrix in the presence of
PDC-109 (P/L weight ratio of 2.5) are shown. In each set of four
spectra the upper pair corresponds to the composite spectrum of the
PDC-109/lipid complex (solid line) and the motionally restricted
component spectrum (dotted line) that is used for subtraction from
the composite spectrum. The lower pair of spectra corresponds to
the subtraction result (solid line) and a matching £uid lipid refer-
ence spectrum (dotted line). Spectra are all (including di¡erence
spectra) displayed normalized to the same maximum central line
height.
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This equation applies to the selectivity between di¡erent
spin labels in the same protein^lipid complex, i.e. for constant
nt and Nb.
From the two-component spectra shown in Fig. 2 and the
subtraction results given in Table 1, the selectivity of PDC-
109 for di¡erent spin-labelled lipid probes in DMPC mem-
branes containing 20 wt% cholesterol is in the following or-
der: phosphatidylcholinev sphingomyelins phosphatidylseri-
nes androstanolv phosphatidylethanolamineEcholestane.
This trend is consistent with the lipid selectivity order ob-
served for PDC-109 interacting with di¡erent lipid spin labels
in a DMPC host matrix without cholesterol. With the excep-
tion of PE, it is seen from Table 1 also that the absolute
values of the selectivity relative to PC, i.e. Kr/KPCr , are com-
parable for PDC-109 bound to DMPC membranes with and
without cholesterol.
If it is thus assumed that the relative association constant,
Kr, in the presence of cholesterol is equal to that in its ab-
sence, Kor , and further that K
o
r = 1 for spin-labelled PC, then:
nt=Nb
not =N
o
b
¼ f PCo þ ð13f PCo Þ
1=f31
1=f o31
 
ð3Þ
where fo and fPCo are the fractions of a given spin-labelled lipid
and PC, respectively, that are motionally restricted in the
absence of cholesterol. The left-hand side of Eq. 3 is the ratio
of the lipid-binding stoichiometry to the intramembrane lipid/
protein interaction stoichiometry, i.e. the value of nt/Nb, rel-
ative to that in the absence of cholesterol. For spin-labelled
PC, Eq. 3 reduces to:
nt=Nb
not =N
o
b
¼ f
PC
o
f PC
ð4Þ
If the unlabelled host lipid is PC, then Eq. 4 is the most direct
means of determining the e¡ect of cholesterol on the lipid/
protein stoichiometries.
Values of (nt/Nb)/(not /N
o
b) calculated from Eq. 3, by using
the present spin-label data for DMPC membranes with 20
wt% cholesterol and corresponding data of Ramakrishnan et
al. [1] for DMPC membranes without cholesterol, are given in
the ¢nal column of Table 1. With the exception of PE, the
values are comparable for the di¡erent spin labels, consistent
with the assumption that cholesterol does not have a large
e¡ect on lipid selectivity for PDC-109. As mentioned above,
the value of (nt/Nb)/(not /N
o
b) for PC then most directly re£ects
cholesterol-induced changes in the lipid-binding stoichiome-
try. In principle, the decrease in the ratio nt/Nb with choles-
terol could be caused either by an increase in the number of
lipid association sites, Nb, on PDC-109, or by an increase in
binding stoichiometry, 1/nt, of PDC-109 to the membranes, in
either case by approximately 50%. Most likely cholesterol po-
tentiates the interaction between PC membranes and PDC-109
predominantly by the former mechanism, because £uores-
cence titrations have indicated no changes in binding stoichi-
ometry at saturation by cholesterol addition [20].
Lipid-binding experiments have shown PDC-109 does not
interact directly with cholesterol [5]. However, the results ob-
tained in this study as well as our previous studies [1] demon-
strate that the addition of PDC-109 to membranes containing
PC and cholesterol results in an immobilization of the sterol,
suggesting that PC probably mediates the interaction between
PDC-109 and cholesterol. Here we show also that cholesterol
potentiates the association of PDC-109 with lipids. This pro-
vides further insights into our understanding of the process of
cholesterol e¥ux.
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